For Institutions
About
IHH Healthcare Bhd has issued a disclosure that is heavily corrupted, making it unreadable and preventing the extraction of specific operational, financial, or strategic details. Consequently, the implications for the company's performance and stakeholders cannot be determined from this announcement. IHH Healthcare is a major international private healthcare provider based in Malaysia, operating hospitals and healthcare services across Asia and beyond.
IHH Healthcare Bhd has issued a corporate announcement indicating it is addressing certain corporate or financing matters. The announcement contains technical language but suggests no immediate changes to its core hospital and healthcare operations, implying limited short-term operational impact for patients and staff. IHH Healthcare is a major private healthcare provider operating across multiple countries, focusing on specialized medical services.
Raffles Medical Group recommends buying, with a target price of 1.15 yuan and a closing price of 1.00 yuan. It is expected that net profit will increase by 16% year-on-year in the second half of 2025, continuing into 2026 and 2027, achieving double-digit growth. Benefiting from the recovery of local hospital business and improvement in insurance business, the reform of comprehensive health insurance plans will help curb medical cost inflation. Raffles Medical's insurance premiums remain unchanged, providing a competitive advantage. Other catalysts include the improvement of hospital revenue and expenditure balance in China and the advancement of acquisition cases in Vietnam
Thor Medical ASA has granted share options to senior management, including 700,000 options to Therese Kvehaugen and 600,000 options to Mathias Reierth. Each option allows the holder to acquire one share at the exercise price, following the company's remuneration guidelines approved at the annual general meeting on April 11, 2024.
Thomson Medical Group appointed Tong Guiwang as the new chairman, effective from February 1, succeeding Huang Simian. Tong Guiwang will assume the role of independent non-executive chairman, bringing extensive corporate management and investment experience, and is committed to promoting the group's development projects in the Johor Strait. Huang Simian has served as chairman since 2015, successfully leading the company's transformation and expansion. Thomson Medical Group's stock price fell 1.59% on Monday, closing at 0.062 SGD
